GlassScriptPhysician profile
Christopher T Veal
NPI 1235371329
$1,840.92
in general payments reported to CMS, 2019-2025
6 companies · $1,708 in 2025
The $1,708 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.55 · 2021: $13.55 · 2023: $16.37 · 2024: $69.48 · 2025: $1,708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,146 · Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,145.55 |
| Food and Beverage | $648.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $940.18 | 2025 | Optablate, Mild Device Kit |
| Globus Medical, INC. | $691.76 | 2025 | Senza, Vyrsa V1 |
| Nalu Medical, INC. | $103.61 | 2024-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $41.90 | 2024 | Senza |
| Portola Pharmaceuticals, LLC | $33.55 | 2019 | |
| Merck Sharp & Dohme LLC | $29.92 | 2021-2023 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Veal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.